Opposing roles of p38α-mediated phosphorylation and PRMT1-mediated arginine methylation in driving TDP-43 proteinopathy

Opposing roles of p38α-mediated phosphorylation and PRMT1-mediated arginine methylation in driving TDP-43 proteinopathy

Saved in:

Bibliographic Details
Main Authors:	Mari Aikio, Hana M. Odeh, Heike J. Wobst, Bo Lim Lee, Úna Chan, Jocelyn C. Mauna, Korrie L. Mack, Bradley Class, Thomas A. Ollerhead, Alice F. Ford, Edward M. Barbieri, Ryan R. Cupo, Lauren E. Drake, Joshua L. Smalley, Yuan-Ta Lin, Stephanie Lam, Reuben Thomas, Nicholas Castello, Ashmita Baral, Jenna N. Beyer, Mohd A. Najar, John Dunlop, Aaron D. Gitler, Ashkan Javaherian, Julia A. Kaye, George M. Burslem, Dean G. Brown, Christopher J. Donnelly, Steven Finkbeiner, Stephen J. Moss, Nicholas J. Brandon, James Shorter
Format:	Article
Language:	English
Published:	Elsevier 2025-03-01
Series:	Cell Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2211124725001573
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prion-like Spreading of Disease in TDP-43 Proteinopathies
by: Emma Pongrácová, et al.
Published: (2024-11-01)

Extracellular vesicles in TDP-43 proteinopathies: pathogenesis and biomarker potential
by: Elizabeth R. Dellar, et al.
Published: (2025-06-01)

PRMT1-mediated metabolic reprogramming promotes leukemogenesis
by: Hairui Su, et al.
Published: (2025-08-01)

A Twist in Yeast: New Perspectives for Studying TDP-43 Proteinopathies in <i>S. cerevisiae</i>
by: Roberto Stella, et al.
Published: (2025-02-01)

scFv intrabody targeting wildtype TDP-43 presents protective effects in a cellular model of TDP-43 proteinopathy.
by: Yara Al Ojaimi, et al.
Published: (2025-01-01)

scFv intrabody targeting wildtype TDP-43 presents protective effects in a cellular model of TDP-43 proteinopathy
by: Yara Al Ojaimi, et al.
Published: (2025-01-01)

HDAC1 dysregulation induces aberrant cell cycle and DNA damage in progress of TDP‐43 proteinopathies
by: Cheng‐Chun Wu, et al.
Published: (2020-05-01)

Behavioral changes on amyotrophic lateral sclerosis (ALS): a case of ALS/FTD TDP-43 proteinopathy
by: Bruno Lopes dos Santos, et al.
Published: (2012-03-01)

Distinct Pattern of Microgliosis in the Olfactory Bulb of Neurodegenerative Proteinopathies
by: Zacharias Kohl, et al.
Published: (2017-01-01)

PRMT1‐mediated arginine methylation promotes YAP activation and hepatocellular carcinoma proliferation
by: Jian Yu, et al.
Published: (2024-12-01)

Unraveling the Role of Proteinopathies in Parasitic Infections
by: Mikołaj Hurła, et al.
Published: (2025-03-01)

Lycorine protects motor neurons against TDP-43 proteinopathy-induced degeneration in cross-species models with amyotrophic lateral sclerosis
by: Jing Wen, et al.
Published: (2024-12-01)

Study on the Mechanism of QRICH1 Mediating PRMT1 to Regulate the Arginine Methylation Modification of cGAS to Promote Arsenics-Induced Pyroptosis in Hepatocellular Carcinoma Cells
by: Zhang J, et al.
Published: (2025-03-01)

α-synuclein and tau: interactions, cross-seeding, and the redefinition of synucleinopathies as complex proteinopathies
by: Francisco J. Padilla-Godínez, et al.
Published: (2025-03-01)

SON-dependent nuclear speckle rehabilitation alleviates proteinopathies
by: William Dion, et al.
Published: (2025-08-01)

PRMT5 inhibitors: Therapeutic potential in pancreatic cancer
by: Carolin Schneider, et al.
Published: (2025-05-01)

PRMT5-Mediated Arginine Methylation of ACSL4 Attenuates Its Stability and Suppresses Ferroptosis in Renal Cancer
by: Meng Zhang, et al.
Published: (2025-01-01)

TBL2 Promotes Tumorigenesis via PRMT5/WDR77‐Mediated AKT Activation in Breast Cancer
by: Xiuqing Lu, et al.
Published: (2024-12-01)

The methyltransferases PRMT4/CARM1 and PRMT5 control differentially myogenesis in zebrafish.
by: Julie Batut, et al.
Published: (2011-01-01)

Relationship between cerebral small vessel disease and proteinopathies in the medial temporal lobe
by: Valentina Perosa, et al.
Published: (2025-07-01)

PRMT5-mediated methylation of METTL3 promotes cisplatin resistance in ovarian cancer by facilitating DNA repair mechanisms
by: Qiaoxi Xia, et al.
Published: (2025-04-01)

From clinical phenotype to proteinopathy: molecular neuroimaging in neurodegenerative dementias
by: Adalberto Studart-Neto, et al.
Published: (2022-08-01)

Long-read RNA sequencing unveils a novel cryptic exon in MNAT1 along with its full-length transcript structure in TDP-43 proteinopathy
by: Yoshihisa Tanaka, et al.
Published: (2025-07-01)

The protein arginine methyltransferase PRMT1 ameliorates cerebral ischemia–reperfusion injury by suppressing RIPK1-mediated necroptosis and apoptosis
by: Tengfei Liu, et al.
Published: (2025-08-01)

PRMT5-Mediated ALKBH5 Methylation Promotes Colorectal Cancer Immune Evasion via Increasing CD276 Expression
by: Sen Meng, et al.
Published: (2025-01-01)

Complex proteinopathies and neurodegeneration: insights from the study of transmissible spongiform encephalopathies
by: Pedro Piccardo, et al.

Validity and Reliability of Clinical and Patient‐Reported Outcomes in Multisystem Proteinopathy 1
by: Lindsay N. Alfano, et al.
Published: (2025-07-01)

Yeast proteinopathy models: a robust tool for deciphering the basis of neurodegeneration
by: Amit Shrestha, et al.
Published: (2015-11-01)

PRMT5 Promotes Pancreatic Cancer Tumorigenesis via Positive PRMT5/C‐Myc Feedback Loop
by: Fan Yang, et al.
Published: (2025-06-01)

PRMT3 drives PD-L1-mediated immune escape through activating PDHK1-regulated glycolysis in hepatocellular carcinoma
by: Chen-Hong Ding, et al.
Published: (2025-03-01)

Lysine-Targeting Inhibitors of Amyloidogenic Protein Aggregation: A Promise for Neurodegenerative Proteinopathies
by: Kazuma Murakami, et al.
Published: (2025-08-01)

PRMT1-mediated methylation of UBE2m promoting calcium oxalate crystal-induced kidney injury by inhibiting fatty acid metabolism
by: Tianhui Yuan, et al.
Published: (2025-07-01)

PRMT5 Identified as a Viable Target for Combination Therapy in Preclinical Models of Pancreatic Cancer
by: Xiaolong Wei, et al.
Published: (2025-06-01)

Development and In Vitro Characterization of [<sup>3</sup>H]GMC-058 as Radioligand for Imaging Parkinsonian-Related Proteinopathies
by: Andrea Varrone, et al.
Published: (2025-06-01)

Utilization of CoRDS registry to monitor quality of life in patients with VCP multisystem proteinopathy
by: Eiman Abdoalsadig, et al.
Published: (2025-04-01)

PRMT3‐Mediated H4R3me2a Promotes Primary Age‐Related Tauopathy by Driving Tau Hyperphosphorylation in Neuron
by: Haotian Liu, et al.
Published: (2025-07-01)

Targeting PRMT1-mediated methylation of TAF15 to protect against myocardial infarction by inhibiting ferroptosis via the GPX4/NRF2 pathway
by: Guanshen Huang, et al.
Published: (2025-07-01)

Prmt1-mediated methylation regulates Ncoa4 stability to transactivate Adamts genes and promote bone extracellular matrix degradation in chronic hematogenous osteomyelitis
by: Xun Chen, et al.
Published: (2025-05-01)

Tumor-intrinsic PRMT5 upregulates FGL1 via methylating TCF12 to inhibit CD8+ T-cell-mediated antitumor immunity in liver cancer
by: Jiao Sun, et al.
Published: (2025-01-01)

HIGH-SENSITIVITY TEST SYSTEMS BASED ON CONJUGATES «POLYMER MICROSPHERES – BIOLIGANDS» FOR RAPID PROTEINOPATHY DIAGNOSTICS
by: S. A. Kedik, et al.
Published: (2013-08-01)